Concepedia

Taebo Sim

TS

Statistics

Publications

94

Citations

8.7K

H-Index

37

Active since

2006

Affiliations

Korea Institute of Science and Technology(Current)

Dana-Farber Cancer Institute

Korea University

Harvard University

Daegu-Gyeongbuk Medical Innovation Foundation

Taebo Sim is an author at Korea Institute of Science and Technology specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

2006–2024

94

Publications

94

An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1

Carson C. Thoreen, Seong A. Kang, Jae Won Chang et al. · Journal of Biological Chemistry · 2009 · 1.8K citations · Full text

Life Sciences, Oncology, Pharmacology +14

Targeting transcription regulation in cancer with a covalent CDK7 inhibitor

Nicholas Kwiatkowski, Tinghu Zhang, Peter B. Rahl et al. · Nature · 2014 · 900 citations · Full text

Medicine, Cancer Biology, Molecular Biology +12

Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors

Jianming Zhang, Francisco Adrián, Wolfgang Jahnke et al. · Nature · 2010 · 599 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Allosteric inhibitors of Bcr-abl–dependent cell proliferation

Francisco Adrián, Qiang Ding, Taebo Sim et al. · Nature Chemical Biology · 2006 · 378 citations · Full text

Medicine, Oncology, Pharmacology +13

Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development

Katherine A. Donovan, Fleur M. Ferguson, Jonathan W. Bushman et al. · Cell · 2020 · 371 citations · Full text

Engineering, Bioengineering, Biotechnology +2

1–5 of 94